Comparative study between oral steroids, intravitreal triamcinolone and intravitreal bevacizumab in Non Arteritic Anterior Ischemic Optic Neuropathy

Sankara eye hospital Guntur0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年2月21日

试验速览

暂无简介。

•All diagnosed cases of NA- AION with a history of sudden visual loss and an absence of other ocular, systemic or neurological diseases that might influence or explain the patientâ??s visual symptoms, with,
•Optic disc edema (ODE) at onset and must still be present ( for referred cases) for inclusion in this study, with,
•Optic disc related Visual field defects ( in cases where VF analysis is feasible)
•The patient must not have had any treatment for NA-AION prior to our evaluation,

•Patients who had any retinal or optic nerve lesion (Amblyopia, Glaucoma/ Vascular diseases/ Uveitis) or any other factor (e.g., cataract) which could influence the visual status.
•NA-AION patients with only background diabetic retinopathy were included, but those who had active neovascularization, vitreous hemorrhages, traction detachment, DME or other complications influencing the visual acuity or fields are excluded.
•Patients who had a diagnosis of glaucoma and visual field loss are excluded; however, those with history of elevated intraocular pressure and on ocular hypotensive therapy, with a documented normal field prior to the onset of NA-AION, are included.
•Patients with a follow-up of less than 3 months are excluded.

发起方

Sankara eye hospital Guntur